PDB60 ASSESSMENT OF THE INTERVAL BETWEEN FIRST EXENATIDE CLAIM AND LAST PRIOR ORAL ANTIDIABETIC CLAIM
Autor: | Misurski, D, Quimbo, RA, Hou, L, Pawaskar, MD, Wade, R |
---|---|
Zdroj: | In Value in Health 2009 12(3):A108-A108 |
Databáze: | ScienceDirect |
Externí odkaz: |